280 related articles for article (PubMed ID: 21883200)
1. Sumatriptan-naproxen migraine efficacy in allodynic patients: early intervention.
Landy S; Hoagland R; Hoagland NA
Headache; 2012 Jan; 52(1):133-9. PubMed ID: 21883200
[TBL] [Abstract][Full Text] [Related]
2. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
[TBL] [Abstract][Full Text] [Related]
3. Sumatriptan and naproxen sodium for the acute treatment of migraine.
Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ
Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
[TBL] [Abstract][Full Text] [Related]
4. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
Derosier F; Sheftell F; Silberstein S; Cady R; Ruoff G; Krishen A; Peykamian M
Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
[TBL] [Abstract][Full Text] [Related]
5. Double-blind, placebo-controlled, crossover study of early-intervention with sumatriptan 85/naproxen sodium 500 in (truly) episodic migraine: what's neck pain got to do with it?
Calhoun AH; Ford S
Postgrad Med; 2014 Mar; 126(2):86-90. PubMed ID: 24685971
[TBL] [Abstract][Full Text] [Related]
6. Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine.
Silberstein SD; Mannix LK; Goldstein J; Couch JR; Byrd SC; Ames MH; McDonald SA; Lener SE; Toso C
Neurology; 2008 Jul; 71(2):114-21. PubMed ID: 18606965
[TBL] [Abstract][Full Text] [Related]
7. Clarification of developing and established clinical allodynia and pain-free outcomes.
Landy SH; McGinnis JE; McDonald SA
Headache; 2007 Feb; 47(2):247-52. PubMed ID: 17300364
[TBL] [Abstract][Full Text] [Related]
8. Sumatriptan/Naproxen sodium for migraine: efficacy, health related quality of life, and satisfaction outcomes.
Smith T; Blumenthal H; Diamond M; Mauskop A; Ames M; McDonald S; Lener S; Burch S
Headache; 2007 May; 47(5):683-92. PubMed ID: 17501849
[TBL] [Abstract][Full Text] [Related]
9. Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine.
Haberer LJ; Walls CM; Lener SE; Taylor DR; McDonald SA
Headache; 2010 Mar; 50(3):357-73. PubMed ID: 20132340
[TBL] [Abstract][Full Text] [Related]
10. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors.
Jakubowski M; Levy D; Goor-Aryeh I; Collins B; Bajwa Z; Burstein R
Headache; 2005; 45(7):850-61. PubMed ID: 15985101
[TBL] [Abstract][Full Text] [Related]
11. Twelve-month tolerability and safety of sumatriptan-naproxen sodium for the treatment of acute migraine.
Winner P; Cady RK; Ruoff GE; Frishberg BM; Alexander WJ; Zhang Y; Kori SH; Lener SE
Mayo Clin Proc; 2007 Jan; 82(1):61-8. PubMed ID: 17285787
[TBL] [Abstract][Full Text] [Related]
12. Sumatriptan plus naproxen for acute migraine attacks in adults.
Law S; Derry S; Moore RA
Cochrane Database Syst Rev; 2013 Oct; (10):CD008541. PubMed ID: 24142431
[TBL] [Abstract][Full Text] [Related]
13. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
[TBL] [Abstract][Full Text] [Related]
14. Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults.
Law S; Derry S; Moore RA
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD008541. PubMed ID: 27096438
[TBL] [Abstract][Full Text] [Related]
15. Needle-free subcutaneous sumatriptan for triptan users requiring a change in migraine therapy: efficacy and impact on patient-rated functionality, satisfaction, and confidence.
Rothrock JF; Cady RK; Aurora SK; Brandes JL; Myers JA; Fox AW; Farr SJ
Curr Med Res Opin; 2011 Nov; 27(11):2185-91. PubMed ID: 21942531
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological synergy: the next frontier on therapeutic advancement for migraine.
Blumenfeld A; Gennings C; Cady R
Headache; 2012 Apr; 52(4):636-47. PubMed ID: 22221151
[TBL] [Abstract][Full Text] [Related]
17. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
18. Satisfaction with and confidence in needle-free subcutaneous sumatriptan in patients currently treated with triptans.
Cady RK; Aurora SK; Brandes JL; Rothrock JF; Myers JA; Fox AW; Farr SJ
Headache; 2011 Sep; 51(8):1202-11. PubMed ID: 21812775
[TBL] [Abstract][Full Text] [Related]
19. Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes.
Cady RK; Diamond ML; Diamond MP; Ballard JE; Lener ME; Dorner DP; Derosier FJ; McDonald SA; White J; Runken MC
Headache; 2011 May; 51(5):664-73. PubMed ID: 21521204
[TBL] [Abstract][Full Text] [Related]
20. Long-term tolerability of sumatriptan nasal spray in adolescent patients with migraine.
Natarajan S; Jabbour JT; Webster CJ; Richardson MS
Headache; 2004; 44(10):969-77. PubMed ID: 15546259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]